Walmart, Merck in blockchain collaboration with FDA
June 13 (Reuters) - IBM Corp IBM.N, Merck & Co MRK.N, KPMG and Walmart Inc EMT.N said on Thursday they will be a part of U.S. Food and Drug Administration's pilot program that will explore using blockchain to identify, track and trace prescription drugs.
The companies said they would create a shared blockchain network to allow real-time monitoring of products in the pharmaceutical supply chain.
(Reporting by Tamara Mathias in Bengaluru; Editing by Shinjini Ganguli)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.